Literature DB >> 1366931

High-level direct expression of semi-synthetic human interleukin-6 in Escherichia coli and production of N-terminus met-free product.

H Yasueda1, K Nagase, A Hosoda, Y Akiyama, K Yamada.   

Abstract

We have developed a direct expression system for high-level production of recombinant human interleukin-6 (rhIL-6) in Escherichia coli. In this system, (i) the natural N-terminal coding region of the hIL-6 gene was replaced by a synthetic sequence containing A-T rich codons, (ii) dual Shine-Dalgarno (SD) sequences were employed, (iii) an A-T rich segment was inserted in front of the initiation codon to avoid putative mRNA secondary structure in the region and (iv) the natural amber termination codon of the hIL-6 gene was changed to an ocher stop codon. The hIL-6 polypeptide, synthesized at a high level, formed cytoplasmic inclusion bodies. After refolding, the N-terminal methionine was removed by aminopeptidase-P in vitro. The purified recombinant hIL-6 had B-cell differentiation activity equivalent to natural IL-6 from a human T-cell culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366931     DOI: 10.1038/nbt1190-1036

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  6 in total

1.  Genetic characterization of pepP, which encodes an aminopeptidase P whose deficiency does not affect Lactococcus lactis growth in milk, unlike deficiency of the X-prolyl dipeptidyl aminopeptidase.

Authors:  J Matos; M Nardi; H Kumura; V Monnet
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

Review 2.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice.

Authors:  N Nishimura; C Tohyama; M Satoh; H Nishimura; V E Reeve
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  In-vivo processing of the initiator methionine from recombinant methionyl human interleukin-6 synthesized in Escherichia coli overproducing aminopeptidase-P.

Authors:  H Yasueda; Y Kikuchi; H Kojima; K Nagase
Journal:  Appl Microbiol Biotechnol       Date:  1991-11       Impact factor: 4.813

5.  Interleukin-6 and granulocyte colony-stimulating factor synergistically increase peripheral blood progenitor cells in myelosuppressive mice.

Authors:  H Suzuki; A Okano; C Ejima; A Konishi; Y Akiyama; K Ozawa; S Asano
Journal:  Jpn J Cancer Res       Date:  1996-09

Review 6.  Comparative evaluation of recombinant protein production in different biofactories: the green perspective.

Authors:  Matilde Merlin; Elisa Gecchele; Stefano Capaldi; Mario Pezzotti; Linda Avesani
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.